title: Complete blood count, measures of iron status and inflammatory markers in inner-city African Americans with undiagnosed hepatitis C seropositivity.
abstract: BACKGROUND
  Hepatitis C virus (HCV) infection may be associated with thrombocytopenia and increased iron stores in patients receiving medical care. We aimed to determine how often changes in hematologic, iron metabolic and inflammatory markers occur in individuals with undiagnosed HCV in the community.
  
  
  METHODS
  Inner-city African Americans (n=143) were recruited from the community according to reported ingestion of alcohol. They were divided broadly into those who drank more or less than 56 g alcohol/day as assessed by dietary questionnaire. HCV serology was determined and laboratory values were compared according to HCV seropositivity in analyses that adjusted for alcohol consumption.
  
  
  RESULTS
  The prevalence of HCV seropositivity was 23% among men and 29% among women. Levels of hepatocellular enzymes were higher with HCV seropositivity (P<0.0001) but hemoglobin concentrations, white blood cell and platelet counts and serum ferritin concentrations did not differ. The globulin fraction of the serum protein concentration (P=0.002) was increased with HCV seropositivity as expected with chronic inflammation. However, erythrocyte sedimentation rate and serum iron and haptoglobin levels did not differ significantly according to HCV status. Furthermore, multivariate analysis revealed that C-reactive protein was decreased and transferrin concentration was increased with both HCV and alcohol consumption (P<0.014).
  
  
  CONCLUSIONS
  Previously undiagnosed HCV seropositivity has little effect on the complete blood count and body iron stores but appears to perturb the response to an inflammatory stimulus, causing reduced rather than increased circulating CRP concentrations and increased rather than decreased transferrin concentrations.
authors.affiliation: Department of Medicine, Howard University College of Medicine, Washington, DC, USA.
authors.forename: Hilary
authors.initials: H
authors.lastname: Ufearo
authors.forename: Khalid
authors.initials: K
authors.lastname: Kambal
authors.forename: Gladys O
authors.initials: GO
authors.lastname: Onojobi
authors.forename: Mehdi
authors.initials: M
authors.lastname: Nouraie
authors.forename: Charles
authors.initials: C
authors.lastname: Agbemabiese
authors.forename: Sharmin
authors.initials: S
authors.lastname: Diaz
authors.forename: Anita
authors.initials: A
authors.lastname: Aggarwal
authors.forename: Zakari
authors.initials: Z
authors.lastname: Aliyu
authors.forename: Robert E
authors.initials: RE
authors.lastname: Taylor
authors.forename: Victor R
authors.initials: VR
authors.lastname: Gordeuk
mesh_terms: D001741:Black or African American; D000367:Age Factors; D000410:Alanine Transaminase / Q000097:blood; D000428:Alcohol Drinking / Q000097:blood; D000906:Antibodies / Q000097:blood* / Q000276:immunology; D001219:Aspartate Aminotransferases / Q000097:blood; D001663:Bilirubin / Q000097:blood; D001772:Blood Cell Count; D001798:Blood Proteins / Q000378:metabolism; D001799:Blood Sedimentation; D002097:C-Reactive Protein / Q000378:metabolism; D004219:District of Columbia / Q000453:epidemiology; D005260:Female; D006526:Hepatitis C / Q000097:blood* / Q000453:epidemiology / Q000276:immunology; D006801:Humans; D007249:Inflammation / Q000097:blood*; D007501:Iron / Q000097:blood*; D008297:Male; D008875:Middle Aged; D015995:Prevalence; D012709:Serum Albumin / Q000378:metabolism; D014168:Transferrin / Q000378:metabolism; D014505:Urban Population; D005723:gamma-Glutamyltransferase / Q000097:blood
chemical_list: D000906:Antibodies; D001798:Blood Proteins; D012709:Serum Albumin; D014168:Transferrin; D002097:C-Reactive Protein; D007501:Iron; D005723:gamma-Glutamyltransferase; D001219:Aspartate Aminotransferases; D000410:Alanine Transaminase; D001663:Bilirubin